Search Results - "pharmacokinetics"

Determination of parecoxib and valdecoxib in rat plasma by UPLC-MS/MS and its application to pharmacokinetics studies by Mengchun Chen, Wei Sun, Zhe Wang, Chengke Huang, Guoxin Hu, Yijie Chen, Ledan Wang

Connect to this object online.

Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies by Wempe MF, Lightner JW, Miller B, Iwen TJ, Rice PJ, Wakui S, Anzai N, Jutabha P, Endou H

Connect to this object online.

Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice by Javier Reig-López, María del Mar Maldonado, Matilde Merino-Sanjuan, Ailed M. Cruz-Collazo, Jean F. Ruiz-Calderón, Victor Mangas-Sanjuán, Suranganie Dharmawardhane, Jorge Duconge

Connect to this object online.

Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis by Chandrasekaran Padmapriyadarsini, Rajesh Solanki, S. M. Jeyakumar, Anuj Bhatnagar, M. Muthuvijaylaksmi, Bharathi Jeyadeepa, Devarajulu Reddy, Prashanth Shah, Rathinam Sridhar, Vikram Vohra, Namrata Kaur Bhui

Connect to this object online.

Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients by Manuel Mena, Julio-Cesar Garcia, Rosa-Helena Bustos

Connect to this object online.

Pharmacokinetics and pharmacodynamics of bioactive compounds in Penyanqing preparation in THP-1 inflammatory cells induced by Lipopolysaccharide by Linna Gong, Zhishuo Miao, Li Zhang, Birui Shi, Zuoqi Xiao, Panzi Qiu, Menghua Liu, Wei Zou

Connect to this object online.

Effect of renal impairment on the pharmacokinetics and safety of dorzagliatin, a novel dual‐acting glucokinase activator by Jia Miao, Ping Fu, Shuang Ren, Chao Hu, Ying Wang, Chengfeng Jiao, Ping Li, Yu zhao, Cui Tang, Yuli Qian, Rong Yang, Yanli Dong, Jing Rong, Yaohui Wang, Xiaowei Jin, Yu Sun, Li Chen

Connect to this object online.

Determination of cepharanthine in rat plasma by LC-MS/MS and its application to a pharmacokinetic study by Yingbin Deng, Weijun Wu, Sunzhi Ye, Wei Wang, Zhiyi Wang

Connect to this object online.

Pharmacokinetics, Tolerability and Pharmacogenetics of DA-8031 After Multiple Ascending Doses in Healthy Male Subjects by Hwang S, Lee DY, Cho JY, Chung JY, Jang IJ, Yu KS, Lee S

Connect to this object online.

Effect of hepatic and renal impairment on the pharmacokinetics of olanzapine and samidorphan given in combination as a bilayer tablet by Sun L, Yagoda S, Du Y, von Moltke L

Connect to this object online.

Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series by Simone Mornese Pinna, Silvia Corcione, Amedeo De Nicolò, Giorgia Montrucchio, Silvia Scabini, Davide Vita, Ilaria De Benedetto, Tommaso Lupia, Jacopo Mula, Giovanni Di Perri, Antonio D'Avolio, Francesco Giuseppe De Rosa

Connect to this object online.

ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES by E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich

Connect to this object online.

Current Scientific Considerations to Verify Physiologically‐Based Pharmacokinetic Models and Their Implications for Locally Acting Products by Liang Zhao, Paul Seo, Robert Lionberger

Connect to this object online.

Pharmacokinetic variability of factor VIII concentrates in Chinese pediatric patients with moderate or severe hemophilia A by Zhenping Chen, Kun Huang, Gang Li, Yingzi Zhen, Xinyi Wu, Ai Di, Guoqing Liu, Zekun Li, Iorio Alfonso, Runhui Wu

Connect to this object online.

Physiologically‐based pharmacokinetics modeling to investigate formulation factors influencing the generic substitution of dabigatran etexilate by Nashid Farhan, Rodrigo Cristofoletti, Sumit Basu, Sarah Kim, Karthik Lingineni, Sibo Jiang, Joshua D. Brown, Lanyan (Lucy), Lawrence J. Lesko, Stephan Schmidt

Connect to this object online.

Physiologically based pharmacokinetic modeling of levetiracetam to predict the exposure in hepatic and renal impairment and elderly populations by Chaozhuang Shen, Wenxin Shao, Wenhui Wang, Hua Sun, Xiaohu Wang, Kuo Geng, Xingwen Wang, Haitang Xie

Connect to this object online.

Pharmacokinetics of dacarbazine and unesbulin and CYP1A2‐mediated drug interactions in patients with leiomyosarcoma by Lan Gao, Diksha Kaushik, Brian A. Van Tine, Matthew A. Ingham, Steven Attia, Christian F. Meyer, Gary K. Schwartz, Pius Maliakal, John D. Baird, Jiyuan Ma, Rosemary Barrett, Dhiren D'Silva, Kylie O'Keefe, Ronald Kong

Connect to this object online.

Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease by Xuanyou Jin, Jaeseong Oh, Joo-Youn Cho, SeungHwan Lee, Su-jin Rhee

Connect to this object online.

Pharmacokinetic and pharmacodynamic drug-drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers by Dasohm Kim, Minkyu Choi, Byung Hak Jin, Taegon Hong, Choon Ok Kim, Byung Won Yoo, Min Soo Park

Connect to this object online.

Pharmacokinetics and Enterohepatic Circulation of 2-(Quinoline-8-carboxamido)benzoic Acid (2-QBA) in Mice by Ji-Hyeon Jeon, So-Yeon Jeon, Yeon-Ju Baek, Chan-E Park, Min-Koo Choi, Young Taek Han, Im-Sook Song

Connect to this object online.